Aimmune Therapeutics Inc (AIMT)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart
Ticker: AIMT Exchange: NSM


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2017-12-04 2017-11-30 PS Planned sale

Sheehy Douglas T.

See Remarks
3,750 -100.0%
37.00
138,750 USD 		3,750 -100.0% 37.00 138,750 USD
2017-11-13 2017-11-09 PS Planned sale

Sheehy Douglas T.

See Remarks
1,905 -100.0%
33.00
62,865 USD 		1,905 -100.0% 33.00 62,865 USD
2017-10-25 2017-10-23 PS Planned sale

DILLY STEPHEN GEORGE

See Remarks

Executive Director
100 -0.0%
36.55
3,655 USD 		100 -0.0% 36.55 3,655 USD
2017-10-25 2017-10-23 PS Planned sale

DILLY STEPHEN GEORGE

See Remarks

Executive Director
6,960 -2.2%
35.39
246,329 USD 		6,960 -2.2% 35.39 246,329 USD
2017-10-25 2017-10-23 PS Planned sale

DILLY STEPHEN GEORGE

See Remarks

Executive Director
17,472 -5.1%
34.15
596,685 USD 		17,472 -5.1% 34.15 596,685 USD
2017-10-25 2017-10-23 PS Planned sale

DILLY STEPHEN GEORGE

See Remarks

Executive Director
75,468 -18.2%
33.23
2,507,870 USD 		75,468 -18.2% 33.23 2,507,870 USD
2017-10-25 2017-10-23 PS Planned sale

Sheehy Douglas T.

See Remarks
5,625 -100.0%
37.00
208,125 USD 		5,625 -100.0% 37.00 208,125 USD
2017-10-25 2017-10-23 PS Planned sale

Sheehy Douglas T.

See Remarks
7,500 -57.1%
35.63
267,251 USD 		7,500 -57.1% 35.63 267,251 USD
2017-10-25 2017-10-23 PS Planned sale

Sheehy Douglas T.

See Remarks
6,333 -100.0%
35.34
223,826 USD 		6,333 -100.0% 35.34 223,826 USD
2017-10-25 2017-10-23 PS Planned sale

Sheehy Douglas T.

See Remarks
5,003 -44.1%
34.13
170,739 USD 		5,003 -44.1% 34.13 170,739 USD
2017-10-25 2017-10-23 PS Planned sale

Sheehy Douglas T.

See Remarks
22,964 -67.0%
33.25
763,574 USD 		22,964 -67.0% 33.25 763,574 USD
2017-10-25 2017-10-23 PS Planned sale

ADELMAN DANIEL C MD

Chief Medical Officer
3,000 -100.0%
35.46
106,375 USD 		3,000 -100.0% 35.46 106,375 USD
2017-10-25 2017-10-23 PS Planned sale

ADELMAN DANIEL C MD

Chief Medical Officer
1,470 -32.9%
34.27
50,384 USD 		1,470 -32.9% 34.27 50,384 USD
2017-10-25 2017-10-23 PS Planned sale

ADELMAN DANIEL C MD

Chief Medical Officer
5,530 -55.3%
33.25
183,851 USD 		5,530 -55.3% 33.25 183,851 USD
2017-10-18 2017-10-16 PS Planned sale

DILLY STEPHEN GEORGE

President and CEO

Executive Director
1,154 -0.3%
26.24
30,279 USD 		1,154 -0.3% 26.24 30,279 USD
2017-10-06 2017-10-06 PS Planned sale

DILLY STEPHEN GEORGE

President and CEO

Executive Director
4,047 -1.0%
26.31
106,468 USD 		4,047 -1.0% 26.31 106,468 USD
2017-10-06 2017-10-05 PS Planned sale

DILLY STEPHEN GEORGE

President and CEO

Executive Director
14,689 -3.4%
26.24
385,495 USD 		14,689 -3.4% 26.24 385,495 USD
2017-10-06 2017-10-04 PS Planned sale

DILLY STEPHEN GEORGE

President and CEO

Executive Director
30,110 -6.5%
26.26
790,613 USD 		30,110 -6.5% 26.26 790,613 USD
2017-10-06 2017-10-04 PS Planned sale

DILLY STEPHEN GEORGE

President and CEO

Executive Director
50,000 -9.7%
26.21
1,310,740 USD 		50,000 -9.7% 26.21 1,310,740 USD
2017-09-27 2017-09-25 PS Planned sale

DILLY STEPHEN GEORGE

President and CEO

Executive Director
100,000 -16.3%
25.01
2,500,790 USD 		100,000 -16.3% 25.01 2,500,790 USD
2017-09-27 2017-09-25 PS Planned sale

Barrowcliffe Susan E.

General Manager, Europe
20,000 -100.0%
25.00
500,000 USD 		20,000 -100.0% 25.00 500,000 USD
2017-09-27 2017-09-25 PS Planned sale

ADELMAN DANIEL C MD

Chief Medical Officer
10,000 -100.0%
25.00
250,000 USD 		10,000 -100.0% 25.00 250,000 USD
2017-09-11 2017-09-07 PS Planned sale

Rozenman Mary M.

See Remarks
30,000 -99.6%
22.50
675,000 USD 		30,000 -99.6% 22.50 675,000 USD
2017-09-07 2017-09-06 PS Planned sale

Barrowcliffe Susan E.

General Manager, Europe
15,167 -100.0%
22.00
333,709 USD 		15,167 -100.0% 22.00 333,709 USD
2017-09-07 2017-09-05 PS Planned sale

Barrowcliffe Susan E.

General Manager, Europe
3,223 -100.0%
22.00
70,906 USD 		3,223 -100.0% 22.00 70,906 USD
2017-07-31 2017-07-27 PS Planned sale

Barrowcliffe Susan E.

General Manager, Europe

Officer
500 -100.0%
22.00
11,000 USD 		500 -100.0% 22.00 11,000 USD
2017-07-28 2017-07-26 PS Planned sale

DILLY STEPHEN GEORGE

President and CEO

Executive Director
50,000 -7.5%
21.46
1,073,110 USD 		50,000 -7.5% 21.46 1,073,110 USD
2017-07-25 2017-07-25 PS Planned sale

Barrowcliffe Susan E.

General Manager, Europe

Officer
4,650 -100.0%
22.00
102,300 USD 		4,650 -100.0% 22.00 102,300 USD
2017-07-25 2017-07-24 PS Planned sale

Barrowcliffe Susan E.

General Manager, Europe

Officer
500 -100.0%
22.00
11,000 USD 		500 -100.0% 22.00 11,000 USD
2017-07-25 2017-07-21 PS Planned sale

Barrowcliffe Susan E.

General Manager, Europe

Officer
960 -100.0%
22.00
21,120 USD 		960 -100.0% 22.00 21,120 USD
2017-07-21 2017-07-21 PS Planned sale

Sheehy Douglas T.

See Remarks

Officer
7,460 -100.0%
21.66
161,558 USD 		7,460 -100.0% 21.66 161,558 USD
2017-07-17 2017-07-17 PS Planned sale

Rozenman Mary M.

See Remarks

Officer
300 -69.9%
21.38
6,414 USD 		300 -69.9% 21.38 6,414 USD
2017-07-17 2017-07-14 PS Planned sale

Rozenman Mary M.

See Remarks

Officer
5,666 -97.8%
21.39
121,175 USD 		5,666 -97.8% 21.39 121,175 USD
2017-07-17 2017-07-13 PS Planned sale

Rozenman Mary M.

See Remarks

Officer
8,974 -98.6%
21.47
192,658 USD 		8,974 -98.6% 21.47 192,658 USD
2017-07-06 2017-07-05 PS Planned sale

Rozenman Mary M.

See Remarks

Officer
15,060 -99.2%
21.40
322,212 USD 		15,060 -99.2% 21.40 322,212 USD
2017-07-06 2017-07-03 PS Planned sale

Barrowcliffe Susan E.

General Manager, Europe

Officer
15,000 -100.0%
20.26
303,911 USD 		15,000 -100.0% 20.26 303,911 USD
2017-07-06 2017-07-03 PS Planned sale

Rozenman Mary M.

See Remarks

Officer
30,000 -99.6%
20.57
617,178 USD 		30,000 -99.6% 20.57 617,178 USD
2017-06-27 2017-06-23 PS Planned sale

DILLY STEPHEN GEORGE

President and CEO

Executive Director
49,400 -6.9%
20.21
998,591 USD 		49,400 -6.9% 20.21 998,591 USD
2017-05-15 2017-05-12 B Purchase

BJERKHOLT ERIC

Chief Financial Officer

Officer
5,000 +inf%
19.84
99,210 USD 		5,000 +inf% 19.84 99,210 USD
2017-05-12 2017-05-10 PS Planned sale

DILLY STEPHEN GEORGE

See Remarks

Executive Director
600 -0.1%
20.15
12,090 USD 		600 -0.1% 20.15 12,090 USD
2017-04-05 2017-04-03 PS Planned sale

DeSouza Warren L.

Chief Financial Officer
15,000 -42.0%
21.58
323,736 USD 		15,000 -42.0% 21.58 323,736 USD
2017-03-23 2017-03-21 PS Planned sale

DeSouza Warren L.

Chief Financial Officer
10,000 -32.6%
22.95
229,500 USD 		10,000 -32.6% 22.95 229,500 USD
2016-11-15 2016-11-11 PS Planned sale

DILLY STEPHEN GEORGE

See Remarks

Executive Director
25,000 -3.4%
25.00
625,000 USD 		25,000 -3.4% 25.00 625,000 USD
2016-11-15 2016-11-11 PS Planned sale

DILLY STEPHEN GEORGE

See Remarks

Executive Director
23,696 -3.1%
25.02
592,990 USD 		23,696 -3.1% 25.02 592,990 USD
2016-11-15 2016-11-11 PS Planned sale

Barrowcliffe Susan E.

General Manager, Europe

Officer
20,000 -100.0%
25.00
500,000 USD 		20,000 -100.0% 25.00 500,000 USD
2016-11-15 2016-11-10 PS Planned sale

DILLY STEPHEN GEORGE

See Remarks

Executive Director
1,304 -0.2%
25.00
32,600 USD 		1,304 -0.2% 25.00 32,600 USD
2016-11-10 2016-11-08 PS Planned sale

Barrowcliffe Susan E.

General Manager, Europe

Officer
15,000 -100.0%
20.00
300,000 USD 		15,000 -100.0% 20.00 300,000 USD
2016-11-04 2016-11-04 PS Planned sale

Rozenman Mary M.

See Remarks

Officer
24,096 -100.0%
17.60
424,090 USD 		24,096 -100.0% 17.60 424,090 USD
2016-10-07 2016-10-05 PS Planned sale

Rozenman Mary M.

See Remarks

Officer
25,000 -100.0%
16.80
420,000 USD 		25,000 -100.0% 16.80 420,000 USD
2016-09-09 2016-09-08 PS Planned sale

Rozenman Mary M.

See Remarks

Officer
30,000 -100.0%
16.80
504,000 USD 		30,000 -100.0% 16.80 504,000 USD
2016-06-02 2016-05-31 S Sale

Foresite Capital Management II, LLC

Major owner
120,000 -33.8%
15.23
1,827,360 USD 		120,000 -33.8% 15.23 1,827,360 USD
2016-06-02 2016-05-31 S Sale

Foresite Capital Management II, LLC

Major owner
120,000 -2.9%
15.23
1,827,360 USD 		120,000 -2.9% 15.23 1,827,360 USD
2016-03-31 2016-03-29 B Purchase

Longitude Capital Partners II, LLC

Major owner
45,440 +0.6%
14.15
642,817 USD 		45,440 +0.6% 14.15 642,817 USD
2016-03-31 2016-03-29 B Purchase

ENRIGHT PATRICK G

Non-Executive Director Major owner
45,440 +0.6%
14.15
642,817 USD 		45,440 +0.6% 14.15 642,817 USD
2016-03-31 2016-03-29 B Purchase

Longitude Capital Partners II, LLC

Major owner
33,064 +0.4%
13.50
446,318 USD 		33,064 +0.4% 13.50 446,318 USD
2016-03-31 2016-03-29 B Purchase

ENRIGHT PATRICK G

Non-Executive Director Major owner
33,064 +0.4%
13.50
446,318 USD 		33,064 +0.4% 13.50 446,318 USD
2015-08-26 2015-08-24 B Purchase

Foresite Capital Management II, LLC

Major owner
25,485 +7.7%
19.65
500,900 USD 		25,485 +7.7% 19.65 500,900 USD
2015-08-11 2015-08-11 B Purchase

Foresite Capital Management II, LLC

Major owner
17,035 +5.5%
20.50
349,199 USD 		17,035 +5.5% 20.50 349,199 USD
2015-08-11 2015-08-11 B Purchase

Foresite Capital Management II, LLC

Major owner
312,500 +inf%
16.00
5,000,000 USD 		312,500 +inf% 16.00 5,000,000 USD
2015-08-11 2015-08-11 B Purchase

Foresite Capital Management II, LLC

Major owner
312,500 +8.3%
16.00
5,000,000 USD 		312,500 +8.3% 16.00 5,000,000 USD
2015-08-11 2015-08-11 B Purchase

Longitude Capital Partners II, LLC

Major owner
312,500 +4.4%
16.00
5,000,000 USD 		312,500 +4.4% 16.00 5,000,000 USD
2015-08-11 2015-08-11 B Purchase

ENRIGHT PATRICK G

Non-Executive Director Major owner
312,500 +4.4%
16.00
5,000,000 USD 		312,500 +4.4% 16.00 5,000,000 USD
2015-08-11 2015-08-11 B Purchase

Iwicki Mark T

Non-Executive Director
20,000 +inf%
16.00
320,000 USD 		20,000 +inf% 16.00 320,000 USD
2015-08-11 2015-08-11 B Purchase

MCDADE MARK

Non-Executive Director
16,660 +inf%
16.00
266,560 USD 		16,660 +inf% 16.00 266,560 USD
2015-08-11 2015-08-11 B Purchase

FALBERG KATHRYN E

Non-Executive Director
25,000 +35.8%
16.00
400,000 USD 		25,000 +35.8% 16.00 400,000 USD